Licensed Medicines


The Group represents Specialty Medicines biopharma companies in key Emerging Markets through licensing and partnership agreements, whereby FarmaMondo covers regulatory approvals, pricing and reimbursement, medical affairs as well as marketing and sales.
Complimentary to our Named Patient services, the FarmaMondo Group’s Licensed Medicines distribution capabilities allow an optimal life cycle management in several of the most promising Emerging Markets.

A staged approach, where a therapy is initially supplied on a Named Patients basis and, in a later stage, gains a marketing authorization optimizes the drug potential and market access investments. FarmaMondo Group offers regional partnerships for commercialization of Specialty Medicines in Switzerland, Russia and CIS region, Baltics, Middle East, and in certain countries in Latin America. Pharmaceutical and biotech companies wishing to join our growing global partnerships portfolio, please contact us at


  • If you would like to send us a general enquiry, please complete the following form.